内視鏡止血デバイス市場：セグメント別規模、シェア、法規制、償還、インターベンション、2036年までの予測

内視鏡的止血デバイスは、消化管（GI）出血の管理に使用されるデバイスで構成され、しばしば治療の第一線として機能します。内視鏡的止血デバイスは一般的に、機械的デバイス（クリップ、結紮器、縫合器、ステント）、注入デバイス（注入針）、温熱デバイス（止血プローブ、止血鉗子、ヒータープローブ、アルゴンプラズマ凝固、高周波焼灼、凍結療法）、局所デバイス（止血スプレー）に分類されます。

内視鏡的止血術は消化管出血の治療に用いられる手技であり、治療の第一選択として用いられます。内視鏡的止血法の適応にはさまざまな上部および下部消化管出血疾患が含まれます。上部消化管出血には主に消化性潰瘍出血と静脈瘤出血が含まれ、下部消化管出血による入院の病因としては憩室出血と良性肛門出血が最も一般的です。

当レポートは、世界の内視鏡止血デバイス市場について詳細に考察し、市場における競合情勢、SWOT分析、2036年までの市場予測、地域、国別の動向などを提供しています。

目次

現在上市されている内視鏡止血デバイスと競合情勢

• 主要な業界動向の洞察
• 内視鏡止血デバイスのセグメント別総市場収益と2015年～2036年の市場展望
• セグメント別のインターベンション総数、台数、平均販売価格、市場価値に関する詳細データ

世界、地域、国別の洞察

• 内視鏡止血デバイス市場のSWOT分析
• 内視鏡止血デバイス市場に関する競合力学の洞察と動向
• 国別の医療制度の概要
• 国別の償還政策
• 国別の医療技術に関する規制の状況

Endoscopic Hemostasis Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Endoscopy Devices therapeutic area.

Endoscopic Hemostasis Devices consists of devices employed in the management of Gastrointestinal (GI) bleeding and often acts as the first line of therapy. Endoscopic Hemostasis Devices are generally classified into mechanical devices (clips, ligation devices, suturing devices, stents), injection devices (injection needles), thermal devices (hemostatic probes, hemostatic forceps, heater probe, argon plasma coagulation, radiofrequency ablation, and cryotherapy) and topical devices (hemostatic spray).

Endoscopic Hemostasis is a technique employed in the management of Gastrointestinal (GI) bleeding and often acts as the first line of therapy. The indications of endoscopic hemostasis technique include various upper and lower gastrointestinal bleeding diseases. Upper GI bleeding mainly includes peptic ulcer bleeding and variceal bleeding while diverticular bleeding and benign anorectal bleeding are the most common etiologies for hospital admissions with lower GI bleeding.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Endoscopic Hemostasis Devices and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Endoscopic Hemostasis Devices market revenue by segment and market outlooks from 2015-2036.
• Granular data on total Interventions, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Endoscopic Hemostasis Devices market.
• Competitive dynamics insights and trends provided for Endoscopic Hemostasis Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, ConMed Corp, Wilson-Cook Medical Inc, ERBE Elektromedizin GmbH, Olympus Corp, United States Endoscopy Group Inc, Micro-Tech Nanjing Co Ltd, Integra LifeSciences Holdings Corp, Medline Industries LP, Diversatek Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Endoscopic Hemostasis market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Endoscopic Hemostasis Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Endoscopic Hemostasis Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Endoscopic Hemostasis Devices market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.